Acnecur

Quick links to important sections

Acnecur

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acnecur

Property Description
Active ingredient Isotretinoin
Form Soft Gelatin Oral Capsule
Pharmacological class Systemic Retinoid (Dermatology Agent)
Common use Severe Acne Vulgaris (General Context)
Origin Synthetic Vitamin A Derivative

The medicinal entity Acnecur is a prescription-only medication classified as a potent Systemic Retinoid and a focused Dermatology Agent. Its sole active ingredient is Isotretinoin, the 13-cis isomer of Retinoic Acid.


What Type of Medicine is Acnecur (Isotretinoin)?

Acnecur is a powerful Systemic Acné Therapy designed to treat severe, persistent forms of acne by acting internally throughout the body. The drug belongs to the pharmacological class of retinoids, which are structurally and functionally related to Vitamin A. As a Systemic Retinoid, it is administered orally to ensure the active compound is absorbed into the bloodstream. Isotretinoin is primarily characterized by its ability to modulate cell proliferation and differentiation. This mechanism is clinically recognized for providing profound, long-term therapeutic control over acne. This systemic approach distinguishes it from topical acne treatments, positioning it as a foundational solution for recalcitrant cases of Acne Vulgaris that have not responded adequately to standard localized therapies.


Composition and Origin: Is Acnecur a Vitamin A Derivative?

The active substance Isotretinoin is chemically a Synthetic Retinoid, manufactured as a highly specific therapeutic derivative of Vitamin A. The medicine is supplied as a Soft Gelatin Capsule for oral consumption. The drug works by altering sebum production and the structure of the pilosebaceous unit. This soft capsule formulation is crucial because Isotretinoin is a lipophilic (fat-soluble) compound; the presence of an oily vehicle within the capsule optimizes the dissolution and subsequent systemic administration of the active ingredient, making the therapy predictably available throughout the body.


What is the General Purpose of Systemic Retinoid Therapy?

The general therapeutic purpose of Acnecur is to profoundly interrupt the biological processes that cause severe acne. This is a monosemantic drug whose primary functional goals include enforcing the normalization of cell growth within the hair follicles, achieving a powerful reduction of sebum production from the oil glands, and providing anti-inflammatory modulation. This comprehensive approach targets the root causes of the condition, offering a fundamental biological intervention for persistent skin concerns, making it a key treatment option when managing severe nodular or cystic acne.

Regulatory References

  1. Isotretinoin - StatPearls - NCBI Bookshelf
  2. Isotretinoin - EMA Referral Page
  3. Isotretinoin SmPC - mechanism of action

What side effects are possible with Acnecur?

Possible Side Effects and Safety Information

Acnecur (Isotretinoin) is associated with a wide-ranging safety profile, classified based on frequency in official regulatory documents. The most critical regulatory constraint is the absolute prohibition of use during pregnancy due to a high risk of severe birth defects (teratogenicity), an official serious adverse reaction.


Frequency-Classified Adverse Reactions

The most prevalent effects, documented as Very Common (1/10) in official labeling, are often extensions of the drug's activity, primarily affecting the skin and mucous membranes. These include Cheilitis (lip dryness/inflammation), generalized dry skin and eye dryness (e.g., conjunctivitis), and musculoskeletal pain (arthralgia, myalgia, back pain). Common effects (1/100 to <1/10) include headache and changes in blood parameters like increased liver enzymes (transaminases) and altered blood lipids.


Serious Safety Considerations

The regulatory label documents several rare but clinically significant adverse reactions. These include reports of severe Psychiatric Disorders (depression, suicidal ideation, psychosis), Inflammatory Bowel Disease (colitis/ileitis), Acute Pancreatitis, and a neurological condition known as Pseudotumor Cerebri (benign intracranial hypertension). Extremely rare, severe skin reactions such as Stevens-Johnson Syndrome (SJS) have also been documented.


Safety Constraints and Special Populations

Specific regulatory safety restrictions include the prohibition of simultaneous use with Vitamin A supplements and Tetracycline antibiotics to avoid risks like Hypervitaminosis A and Pseudotumor Cerebri, respectively. For pediatric patients, there is a very rare documented risk of effects on bone growth, specifically premature epiphyseal closure. Regular monitoring of liver function and blood lipid levels is a mandatory safety requirement due to the drug's predictable metabolic effects.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory information for Acnecur (Isotretinoin) addresses the risk of overdose, which is primarily linked to the drug's classification as a potent Systemic Retinoid and derivative of Vitamin A.

Overdose manifestations typically align with symptoms of acute Hypervitaminosis A. Officially documented signs may include severe and persistent headaches, nausea, vomiting, vertigo, and drowsiness (somnolence). While acute toxicity is generally classified as low, excessive exposure carries the risk of inducing or exacerbating serious retinoid-related conditions, such as Pseudotumor Cerebri (Benign Intracranial Hypertension).

Required Emergency Actions

Overdose Context Mandated Regulatory Action
Any suspected overdose Seek immediate medical attention (e.g., contact emergency services or a poison control center).
Development of severe symptoms Requires immediate medical attention, particularly for persistent headache or signs of neurological effects.

Management and Antidote Status

Management of an overdose is officially limited to symptomatic and supportive treatment. Regulatory documents explicitly state that no specific antidote is known for Isotretinoin toxicity. Hospital monitoring or observation may be required following significant ingestion to manage any potential central nervous system effects.

Therapeutic Uses of Acnecur

What Acnecur Treats: Main Uses and Benefits

Acnecur (Isotretinoin) is generally considered relevant within systemic therapy for Severe Acne Vulgaris, when conventional treatments may have proven insufficient. The therapy is relevant in clinical settings for patients experiencing severe nodular acne that is generally unresponsive to conventional therapy.

This medication is primarily used for managing the highest grades of acne, which are commonly used across conditions presenting with acute episodes of hard, painful nodules, fluid-filled cysts, and severe papulopustular acne. It addresses the severe, persistent symptoms of inflammation, which helps ease the overall symptom burden in affected areas like the face, chest, and back. It is considered a relevant therapeutic option for recalcitrant acne—cases that are resistant to standard therapies, including extended courses of systemic antibiotics.

It may assist with maintaining functional stability in situations where the severity of the lesions poses a high risk of causing permanent, disfiguring scarring. This significant reduction in severe lesions supports the patient by helping to ease the overall psychosocial burden.


Quick Fact: Symptom Management in Recalcitrant Nodulocystic Acne

This therapy is mainly applied when the disease is severe, persistent, and has failed to respond to multiple traditional treatment protocols. It supports the management of deep, inflammatory lesions and may assist with reducing the physical and emotional distress associated with scarring.

Eligibility and Restrictions for Use

Who Can and Cannot Use Acnecur? Official Regulatory Information

The official eligibility profile for Acnecur (Isotretinoin) is strictly defined by regulatory bodies due to its potent nature and absolute contraindication in pregnancy.

Eligibility Status

Population Group Regulatory Status
Pregnant Females Absolute Contraindication
Females of Childbearing Potential Restricted Use
Patients Aged < 12 Years Not Recommended
Patients with Severe Recalcitrant Acne Approved Use

Use is absolutely prohibited for any female who is pregnant or who may become pregnant, as the drug is a Pregnancy Category X agent causing severe birth defects. Females who can become pregnant must enroll in a mandated Risk Evaluation and Mitigation Strategy (REMS) program, commit to using two forms of effective contraception, and undergo monthly pregnancy testing.

Acnecur is approved for patients 12 years of age and older with severe nodular acne that has not responded to other treatments; use is not recommended for children under 12. Use is also contraindicated in patients with a known hypersensitivity to the drug, pre-existing hypervitaminosis A, and those taking tetracyclines or Vitamin A supplements.

Patients with hepatic impairment, renal impairment, diabetes, or a history of psychiatric disorders are subject to special monitoring and cautious use as defined in the official labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents define the interaction profile of Acnecur (Isotretinoin) primarily through pharmacodynamic restrictions and additive risk, rather than common metabolic interactions. The official information mandates strict constraints on co-administration with several substance categories.

Contraindicated Combinations and Additive Risk

Co-administration with tetracycline antibiotics (e.g., minocycline, doxycycline) is formally contraindicated. This restriction is due to a documented risk of developing benign intracranial hypertension (pseudotumor cerebri), a serious additive effect on the central nervous system.

Similarly, the concurrent use of Vitamin A supplements or any other systemic retinoids is strictly prohibited. This is to avoid a serious pharmacodynamic risk of hypervitaminosis A, which represents an additive systemic toxicity.

Efficacy and Pre-existing Condition Constraints

Caution is advised when using phenytoin or systemic corticosteroids alongside Acnecur, as regulatory labeling notes a potential for additive bone-loss effects. Additionally, the herbal product St. John's Wort should be avoided because it may reduce the efficacy of oral contraceptives, thereby compromising the mandatory pregnancy prevention regimen required for this systemic retinoid.

Furthermore, the medicine is contraindicated in patients with hepatic insufficiency. This prohibition is based on the official assessment that impaired liver function may lead to the slower clearance of the drug, increasing overall systemic exposure.

Mechanism of Action

Acnecur, a retinoid compound, is a systemic drug that primarily targets the sebaceous glands within the pilosebaceous unit of the skin.

Its mechanism involves modulation of gene expression by acting as a retinoid and/or pro-drug, which is converted to active metabolites, such as tretinoin (all-trans retinoic acid) and 4-oxo-isotretinoin. These metabolites function as agonists for Retinoic Acid Receptors (RARs), particularly RAR-gamma, and Retinoid X Receptors (RXRs), which are nuclear receptors present in target cell nuclei.

Ligand binding to these nuclear receptors leads to the formation of heterodimers (RAR-RXR) that bind to specific Retinoic Acid Response Elements (RAREs) on the DNA, modulating transcription. This downstream cascade leads to an induction of apoptosis (programmed cell death) specifically in sebocytes.

The resulting involution (shrinking) of the sebaceous glands causes a substantial, dose-dependent decrease in sebum production. Additionally, the drug modifies keratinocyte differentiation and cellular proliferation within the follicular epithelium, thereby normalizing the process of keratinization.

Dosage and Administration Information

How Acnecur Is Used: Official Administration Guidelines

Acnecur (isotretinoin) is a potent systemic retinoid that is used within the framework of established medical protocols. This section provides the key procedural and dosing guidelines that define the appropriate use of the medicine, ensuring proper absorption and adherence to the structured treatment protocol.


Official Administration and Dosage

Instruction Category Guideline Detail
Route of Administration The medicine is administered orally as a Soft Gelatin Capsule.
Standard Dosing Schedule Dosing is typically weight-based, starting at 0.5 mg/kg/day. The standard range is 0.5 to 1 mg/kg/day.
Frequency The total daily dose is usually taken in two divided doses (BID).

Contextual and Time-Based Instructions

Acnecur capsules must be swallowed whole with a full glass of liquid. Because the active ingredient is fat-soluble, it is a key administration requirement that the dose be taken with a meal (preferably a high-fat meal) to maximize gastrointestinal absorption and ensure the drug is available systemically. Capsules must not be crushed, broken, or chewed.

Treatment Course Duration: Therapy is structured as a time-limited course, typically lasting 15 to 20 weeks. If a second course is deemed necessary by a prescriber, a waiting period of at least 8 weeks following the completion of the first course is required before retreatment may be initiated. Dose adjustments for adolescents (12 years) follow the same weight-based rules as adults.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Acnecur (Isotretinoin)


The Core Evidence: Studies for Severe, Recalcitrant Acne Vulgaris

Research into Acnecur was studied for its use in conditions characterized by severe, nodular acne, particularly cases where conventional therapies may have proven insufficient. The evidence base includes Randomized Controlled Trials (RCTs) and systematic reviews. These studies focused on observing measured differences during treatment periods typically lasting a few months (ranging from approximately 15 to 32 weeks).

The main areas research examined were outcomes related to physical symptoms and the clinical state of the skin. This involved researchers measuring the changes in the number of nodules and cysts and evaluating the patterns of change in acne severity using standardized scales. Scientific literature and major guideline bodies grade the quality of evidence for the evaluation of short-term clinical outcomes in severe cases as High.


Long-Term Studies and Durability of Effect

To understand patterns after the medication course is finished, researchers have conducted observational cohort studies, which tracked patients for extended follow-up durations. These studies research examined the long-term status of the observed symptoms and the rates of acne recurrence (relapse) over periods extending up to several years. Findings describe patterns observed, but certainty remains low for predicting long-term outcomes for individuals, and the long-term effects are not fully established across all patient characteristics.


Study Quality and Key Limitations of the Evidence Base

Scientific reviews consistently point out several research limitation frames. One major challenge is the heterogeneity (variability) of the findings concerning the recurrence rate, often attributed to the lack of a universal, standardized definition of "acne relapse." Another key limitation is the uncertainty surrounding the optimal cumulative dose required to achieve the most durable long-term outcomes, as research findings on this topic were mixed or inconsistent across the full range of doses studied.

Key Studies & References

  1. A systematic review of isotretinoin dosing in acne vulgaris
  2. Acne Relapse Rate and Predictors of Relapse Following Treatment with Oral Isotretinoin
  3. New NICE guidance on acne vulgaris: implications for first-line management in primary care

Frequently Asked Questions (FAQ)

Common questions about Acnecur (FAQ)


Q: Why is Acnecur typically only available by prescription?

A: The drug is designated as a Prescription-Only Medicine due to the extremely high risk of causing severe birth defects (teratogenicity) if taken during pregnancy. Because of this critical safety constraint, its use is strictly restricted and monitored through a mandated risk management program (such as the iPLEDGE REMS program in the U.S. or similar regulatory systems).

Q: Does Acnecur commonly cause stomach or digestive issues?

A: Common digestive issues reported include nausea, vomiting, or mild diarrhea. Official documents also note that while rare, serious adverse events like Inflammatory Bowel Disease have been reported. This information is provided in the official documentation for patient awareness.

Q: Does Acnecur interact with oral contraceptive (birth control) pills?

A: Studies have shown small, inconsistent decreases in the blood levels of components found in some hormonal oral contraceptives. Due to the extremely serious risk of birth defects, official documents require patients of childbearing potential to commit to using two acceptable forms of effective contraception during and after treatment.

Q: Are there specific foods or dietary supplements that interact with Acnecur?

A: The capsule must be taken with a meal, and ideally with a high-fat meal, to ensure the active ingredient is properly absorbed by the body. The concurrent use of Vitamin A supplements is strictly prohibited to avoid systemic toxicity. No specific dietary restrictions beyond the requirement to take the capsule with food are generally noted.

Q: Will the acne return or get worse after the person stops taking Acnecur?

A: Studies and official information indicate that the goal of treatment is a substantial and long-term reduction of acne symptoms. However, not everyone achieves permanent clearance, and a significant percentage of individuals may experience a relapse (return of acne) and might require a second course of treatment.

Q: Is Acnecur classified as the same type of drug as older treatments like antibiotics for acne?

A: Acnecur (isotretinoin) is classified as a potent Systemic Retinoid, which is derived from Vitamin A. Regulatory documents state that it is typically reserved for cases of severe acne that have not responded adequately to conventional therapies, which often includes systemic antibiotics.

Q: Is Acnecur approved by major regulatory bodies like the FDA or EMA?

A: The drug is approved by major regulatory bodies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Approval is specifically for the treatment of severe, persistent nodular acne in eligible patients.

Q: Does Acnecur carry a 'black box' warning?

A: The official labeling includes a Boxed Warning (the FDA's most serious safety warning). This warning highlights the extremely high risk of severe birth defects (teratogenicity) if the drug is used during pregnancy.

Q: What are the known signs of a serious allergic reaction to Acnecur?

A: Signs of a serious allergic reaction (hypersensitivity) can include a sudden widespread rash, swelling of the face, lips, mouth, or throat, or difficulty breathing or swallowing. Official information indicates that these symptoms are communicated to a healthcare provider immediately.

Q: Are the side effects of Acnecur described as being permanent?

A: Most side effects typically resolve once the patient stops taking the medication. However, in rare instances, official regulatory reports indicate that certain effects, such as dry eyes or decreased night vision, have been reported to persist after discontinuation of therapy.

Q: Is tiredness or fatigue listed as a possible side effect of Acnecur?

A: Fatigue itself is not listed among the very common side effects. However, regulatory documents indicate that feeling tired can sometimes be a sign of a more serious, rare effect, such as inflammation of the liver, which requires mandatory blood test monitoring during treatment.

Q: Is it true that Acnecur causes sun sensitivity?

A: The official product information indicates that the medication may make your skin more sensitive to the sun (photosensitivity). The official safety documentation suggests avoiding excessive sun exposure or UV lamps and utilizing sun protection when exposure is unavoidable.

Q: Can I use Acnecur at the same time as regular moisturizers or cosmetics?

A: It is often recommended to use moisturizers and lip balms to combat dryness, with non-comedogenic and hypoallergenic products being generally preferred. However, official guidance suggests avoiding the concurrent use of abrasive scrubs or other aggressive topical anti-acne products.

Q: Is there a reported interaction between Acnecur and alcohol consumption?

A: Official warnings advise patients to avoid or minimize the consumption of alcohol during treatment. This caution is based on the potential for the combination to increase the risk of elevated blood fats (triglycerides) and potential liver problems, both of which are monitored during therapy.

Q: How long does it typically take before a patient starts seeing results from Acnecur?

A: Studies and patient guidance often indicate that initial improvement typically begins after one to two months of starting the treatment course. Full results depend on the individual and the total length of the therapy.

Q: When is the peak effect or improvement usually reported after starting Acnecur?

A: The most significant level of improvement is often reported toward the end of the treatment course (typically 15 to 20 weeks). Furthermore, the official information suggests that improvement may continue for up to 8 weeks after the medication is fully discontinued.

Q: What is generally advised if a person forgets to take a scheduled dose of Acnecur?

A: The official administration guidelines describe skipping the missed dose and taking the next scheduled dose at the usual time. Official instructions emphasize the importance of not taking two doses at the same time to compensate for a missed dose.

Q: Is Acnecur suitable for older adults or elderly patients?

A: While specific studies have not demonstrated geriatric-specific problems that strictly limit its use, official information indicates that elderly patients may be more susceptible to certain serious unwanted effects. Caution and special monitoring may be required in this population.

Q: What is the meaning of the official term 'contraindication' in relation to Acnecur?

A: A contraindication is a core medical term used by regulatory bodies to describe a condition or factor that absolutely forbids the use of a medicine because the potential harm would significantly outweigh any benefit. For Acnecur, being pregnant is the absolute contraindication.

Q: Does the medication Acnecur sometimes make acne worse at the beginning of treatment?

A: Official patient guidance documents confirm that when starting treatment, acne may sometimes undergo a temporary worsening, often referred to as an initial flare-up or 'purge.' This phase typically only lasts a short while before the acne begins to clear.

Q: Is there information about Acnecur affecting a person's ability to drive or operate machinery?

A: The medication can cause decreased night vision. Official information states that if decreased night vision occurs, it is required to avoid driving and operating heavy machinery.

How should Acnecur be stored and disposed of?

Storage and Disposal Instructions for Acnecur (Isotretinoin)

Acnecur capsules must be stored according to official regulatory requirements to maintain product stability and safety.


Required Storage Conditions

The medication must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be protected from light, excessive heat, and must not be frozen. It is mandatory to keep the original container tightly closed and store the medication out of the reach of children.


Official Disposal Instructions

Unused or expired Acnecur should be disposed of via a drug take-back program or mail-back envelope when available. If not, the medication may be mixed with an undesirable substance (e.g., coffee grounds) and sealed in a container before discarding in household trash. Do not flush the capsules down the sink or toilet. All personal information should be scratched out from the label prior to disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Acnecur found in:

A-Z Index: